Til børnesår var Altargo mere effektivt end placebo, idet behandlingen virkede hos 119 (85, 6%) af de 139 patienter, der fik Altargo, og hos 37 (52, 1%) af de 71 patienter, der fik placebo.
In patients with impetigo, Altargo was more effective than placebo, with 119 (85.6%) of the 139 patients using Altargo and 37 (52.1%) of the 71 using placebo responding to treatment.